Multiple-Dose, Open-Label, Randomized, Safety and Pharmacokinetic Study of Tipranavir in Combination With Low-Dose Ritonavir in HIV-Infected Pediatric Patients.

Trial Profile

Multiple-Dose, Open-Label, Randomized, Safety and Pharmacokinetic Study of Tipranavir in Combination With Low-Dose Ritonavir in HIV-Infected Pediatric Patients.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Aug 2011

At a glance

  • Drugs Tipranavir (Primary) ; Ritonavir
  • Indications HIV infections; HIV-1 infections
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Boehringer Ingelheim Pharmaceuticals
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 17 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Apr 2010 Planned end date changed from 1 Mar 2010 to 1 Jun 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top